Ketogenesis and Ketone Excretion Before and After Empagliflozin Use in Type 1 Diabetes
Abstract
Adjunctive-to-insulin sodium glucose co-transporter 2 (SGLT2) inhibition has clinically meaningful benefits in type 1 diabetes (T1D) but represents a component cause of diabetic ketoacidosis (DKA) whose risk appears higher in...
Paper Details
Title
Ketogenesis and Ketone Excretion Before and After Empagliflozin Use in Type 1 Diabetes
Published Date
Nov 1, 2021
Journal
Volume
45
Issue
7
Pages
S7 - S7
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History